Synthesis, in-vitro biological evaluation, and molecular docking study of novel spiro-β-lactam-isatin hybrids
- 10 May 2022
- journal article
- research article
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 31 (6) , 1026-1034
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Shiraz University
This publication has 37 references indexed in Scilit:
- Isatin as a Strategic Motif for Asymmetric CatalysisChemCatChem, 2013
- Novel thiolactone–isatin hybrids as potential antimalarial and antitubercular agentsBioorganic & Medicinal Chemistry Letters, 2011
- Computational analysis of binding between malarial dihydrofolate reductases and anti-folatesMalaria Journal, 2010
- Next‐generation antimalarial drugs: hybrid molecules as a new strategy in drug designDrug Development Research, 2009
- Selection of a trioxaquine as an antimalarial drug candidateProceedings of the National Academy of Sciences, 2008
- Trioxaquines Are New Antimalarial Agents Active on All Erythrocytic Forms, Including GametocytesAntimicrobial Agents and Chemotherapy, 2007
- Synthesis and biological evaluation of unprecedented classes of spiro-β-lactams and azido-β-lactams as acyl-CoA:cholesterol acyltransferase inhibitorsBioorganic & Medicinal Chemistry Letters, 2007
- N-Thiolated β-lactams: A new family of anti-Bacillus agentsBioorganic & Medicinal Chemistry Letters, 2006
- Natural Product Hybrids as New Leads for Drug DiscoveryAngewandte Chemie International Edition, 2003
- The chemistry of isatins: a review from 1975 to 1999Journal of the Brazilian Chemical Society, 2001